Implementation Science is a premier open-access journal published by BMC that has been at the forefront of advancing the field of implementation research since its inception in 2006. With an impressive reputation, this journal has consistently ranked in the Q1 quartile across various categories including Health Informatics, Health Policy, Medicine, and Public Health, reflecting its significant impact and relevance in shaping policy and practice. The journal's robust metrics, including a Scopus rank of #7 in Health Policy and #15 in Public Health, underline its credibility and the high-quality scholarship it publishes. By providing an open access platform, Implementation Science ensures that vital research findings reach a broad audience, facilitating knowledge translation and improving health outcomes on a global scale. Researchers, practitioners, and students engaged in the fields of health services research, policy implementation, and public health will find this journal to be an invaluable resource in their quest for evidence-based solutions.

Welcome to the Alexandria Journal of Medicine, a premier open-access publication dedicated to advancing medical knowledge and practice since its inception in 2016. Published by the respected Taylor & Francis Ltd, this journal provides a platform for the dissemination of innovative research in all areas of medicine. With an increasing focus on accessibility, the journal ensures that its valuable content is available to a global audience, fostering collaboration and dialogue among healthcare professionals, researchers, and students alike. The Alexandria Journal of Medicine encourages rigorous peer-reviewed articles that present novel findings, systematic reviews, and insights into clinical practices, making it an essential resource for those at the forefront of medical research. Leveraging a commitment to quality and relevance, this journal aims to impact the ever-evolving landscape of healthcare and contribute to better health outcomes worldwide.

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

Advances in Rehabilitation Science and Practice is a pioneering journal published by SAGE Publications Ltd., dedicated to advancing the field of rehabilitation science through rigorous research and innovative practice. With the ISSN 2753-6351, this peer-reviewed Open Access journal facilitates the dissemination of knowledge essential for rehabilitation professionals, clinicians, and academicians. It aims to provide a comprehensive platform for studies that explore new methodologies, interventions, and outcome measures in rehabilitation settings. The journal plays a crucial role in bridging the gap between research and practice, fostering collaboration among researchers, healthcare practitioners, and policy-makers to improve patient outcomes across various rehabilitation disciplines. By offering unrestricted access to high-quality research, Advances in Rehabilitation Science and Practice not only enhances visibility for authors but also encourages a global exchange of ideas in this critical area of health science.

Investigacion y Educacion en Enfermeria, published by Universidad de Antioquia, Facultad de Enfermería, stands as a pivotal open-access journal since 1983, contributing significantly to the field of nursing and healthcare education within Colombia and beyond. With its ISSN 0120-5307 and E-ISSN 2216-0280, this journal aims to foster the dissemination of high-quality research, aiming to enhance nursing practices and education aligned with a wide array of domains including Community and Home Care, Family Practice, Geriatrics, and Maternity and Midwifery. The journal's impressive performance in the 2023 Scopus rankings places it in the top quartiles in several categories, reflecting its importance and influence, particularly in Nursing and Health Sciences. By encouraging collaboration and dialogue among researchers, practitioners, and students, Investigacion y Educacion en Enfermeria aspires to serve as an essential resource for advancements in nursing education and service delivery, making vital contributions to the evolving landscape of healthcare.

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

SEXUALLY TRANSMITTED DISEASES is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the investigation and dissemination of research on sexually transmitted infections and related public health issues. This journal, with the ISSN 0148-5717 and E-ISSN 1537-4521, has been a cornerstone of the field since its inception in 1977, with coverage extended to 2024. A testament to its scholarly impact, it holds prestigious rankings in the top quartiles across various categories including Q1 in Dermatology and Q1 in Public Health, Environmental and Occupational Health, underscoring its importance in driving forward critical discussions and advancements in these vital areas of health. With an emphasis on rigorous research and the latest scientific findings, the journal not only serves researchers and professionals but also informs clinical practices, shaping public health policies. While it is not an Open Access journal, it offers a wealth of subscription-based resources highly regarded for their quality and relevance within the medical community.

Istanbul Medical Journal is a prominent open-access journal published by GALENOS PUBL HOUSE, dedicated to disseminating high-quality research in the field of medicine since its inception in 1994. The journal, identifiable by its ISSN 2619-9793 and E-ISSN 2148-094X, serves as a critical platform for healthcare professionals, researchers, and students who aim to share innovative studies and advancements within diverse medical domains. Its commitment to open access ensures that crucial findings and discussions are readily available to a global audience, fostering collaboration and knowledge exchange among the scientific community. Located in Istanbul, Türkiye, the journal not only contributes to the medical literature landscape but also emphasizes the importance of accessibility in research, aligning with current academic trends that prioritize the transmission of knowledge across barriers. As a resource for those involved in healthcare and medical research, the Istanbul Medical Journal plays a vital role in shaping future developments in medicine.

Contemporary Clinical Trials, published by Elsevier Science Inc, stands at the forefront of clinical research, providing a dedicated platform for the dissemination of innovative studies and methodologies in medicine and pharmacology. With an impressive impact factor reflecting its consistent contributions to the field, this journal is categorized in the Q1 quartile for both Medicine (miscellaneous) and Pharmacology (medical) as of 2023. The journal's scope encompasses a broad range of topics pertinent to clinical trial design, execution, and analysis, aiming to enhance the effectiveness and safety of therapeutic interventions. Operating under an Open Access model, it ensures that the latest research is accessible to a global audience, fostering collaboration and discussion among researchers, professionals, and students alike. In publishing high-quality articles since its inception in 2005, Contemporary Clinical Trials continues to shape the future of clinical research with its commitment to excellence and innovation.